
Association between allopurinol use and hepatocellular carcinoma in a case–control study in Taiwan
Author(s) -
KuanFu Liao,
ChengLi Lin,
ShihWei Lai
Publication year - 2018
Publication title -
european journal of hospital pharmacy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.313
H-Index - 14
eISSN - 2047-9964
pISSN - 2047-9956
DOI - 10.1136/ejhpharm-2017-001479
Subject(s) - allopurinol , medicine , confounding , hepatocellular carcinoma , medical prescription , logistic regression , case control study , surgery , pharmacology
Little is known about the role of allopurinol use on the risk of hepatocellular carcinoma (HCC). The study aimed to examine the association between allopurinol use and HCC in Taiwan.